![]() |
Volumn 56, Issue 8, 2005, Pages 909-911
|
Pharmacy costs: Finding a role for quality
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANXIOLYTIC AGENT;
CITALOPRAM;
CLOZAPINE;
FLUOXETINE;
GABAPENTIN;
GENERIC DRUG;
NEUROLEPTIC AGENT;
PSYCHOTROPIC AGENT;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
COST CONTROL;
DRUG COST;
DRUG DOSE REGIMEN;
DRUG FORMULARY;
DRUG UTILIZATION;
HEALTH CARE COST;
HEALTH CARE QUALITY;
HEALTH MAINTENANCE ORGANIZATION;
MEDICAID;
MEDICAL EDUCATION;
MEDICARE;
PHARMACY;
POLYPHARMACY;
PRACTICE GUIDELINE;
PRESCRIPTION;
SHORT SURVEY;
COST CONTROL;
DRUG COSTS;
INSURANCE, PHARMACEUTICAL SERVICES;
MENTAL HEALTH SERVICES;
QUALITY CONTROL;
UNITED STATES;
|
EID: 23244452445
PISSN: 10752730
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ps.56.8.909 Document Type: Short Survey |
Times cited : (7)
|
References (8)
|